Use of SWELL1 inhibitors and modulators to treat type 2 diabetes and obesity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12059403
APP PUB NO 20210369670A1
SERIAL NO

16322709

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides the use of SWELL1 inhibitors and modulators for therapeutic use, e.g., to treat obesity and type 2 diabetes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF IOWA RESEARCH FOUNDATION112 N CAPITOL STREET 6 GILMORE HALL IOWA CITY IA 52242-5500

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Sah, Rajan Iowa City, US 5 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 13, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 13, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 13, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00